Recently, we were published in Progressive Grocer talking about the rise of GLP-1 weight loss drugs and how this is impacting the food and beverage space. The article, “Embracing the Ozempic Boom: How Food and Beverage Companies Need to Adapt” was penned by our very own Shira Horn, EVP here at AMC Global, and she explores how drugs like Ozempic, Wegovy, and Mounjaro are reshaping the way people shop.
As these drugs gain popularity—with projections indicating that 9% of the U.S. population may be using them by 2030—Shira discusses how they are already impacting grocery sales and consumer behavior. Users of these drugs are shifting away from high-calorie, fatty and sugary foods due to side effects like nausea, instead opting for nutrient-dense options like fresh fruits, vegetables and lean proteins. This trend, referred to as the "Ozempic Economy," is prompting food and beverage companies to adapt by developing products that cater to the changing preferences of this growing consumer base.
The article in Progressive Grocer also shares how large food and beverage companies are responding to these trends by launching new products tailored to this category of weight loss drug users with products such as portion-controlled, nutrient-rich meals. To stay competitive, Shira advises brands to conduct consumer-based market research focused on this demographic, allowing them to innovate and develop products that align with the evolving market needs. “Embracing the Ozempic Boom: How Food and Beverage Companies Need to Adapt” emphasizes the importance of proactive product development and strategic planning to remain relevant as these changes continue to shape the grocery industry. To learn more about staying ahead, contact us!